Old Web
English
Sign In
Acemap
>
authorDetail
>
Paolo di Procolo
Paolo di Procolo
Medicine
Intensive care medicine
Alemtuzumab
Multiple sclerosis
cost effectiveness
3
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy
2019
Global & Regional Health Technology Assessment
Sanja Stanisic
Antonio Bertolotto
Patrizia Berto
Paolo di Procolo
Julia Morawski
Show All
Source
Cite
Save
Citations (2)
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study
2018
Claudio Jommi
Patrizio Armeni
Margherita Battista
Paolo di Procolo
Giuseppe Conte
Claudio Ronco
Mario Cozzolino
Anna Maria Costanzo
Umberto di Luzio Paparatti
Gabriella Concas
Giuseppe Remuzzi
Show All
Source
Cite
Save
Citations (8)
Current pipelines for neglected diseases.
2014
PLOS Neglected Tropical Diseases
Paolo di Procolo
Claudio Jommi
Show All
Source
Cite
Save
Citations (3)
1